Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma
Lung cancer is the most common cancer worldwide, leading to high mortality each year. Metabolic pathways play a vital role in the initiation and progression of lung cancer. We aimed to establish a prognostic prediction model for lung adenocarcinoma (LUAD) patients based on a metabolism-associated ge...
Main Authors: | Lulu He, Jiaxian Chen, Feng Xu, Jun Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Molecular Therapy: Oncolytics |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2372770520301509 |
Similar Items
-
Integrated analysis of hypoxia-associated lncRNA signature to predict prognosis and immune microenvironment of lung adenocarcinoma patients
by: Jun Shao, et al.
Published: (2021-01-01) -
Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
by: Zhengliang Tu, et al.
Published: (2021-04-01) -
Identification of a Hypoxia-Associated Signature for Lung Adenocarcinoma
by: Zhuomao Mo, et al.
Published: (2020-06-01) -
Development of an autophagy-related gene prognostic signature in lung adenocarcinoma and lung squamous cell carcinoma
by: Jie Zhu, et al.
Published: (2020-01-01) -
A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma
by: Jiahang Song, et al.
Published: (2021-01-01)